Add BrightSurf on Google Email

Science News Archive July 2018 - Page 37


Page 37 of 38

New drugs to treat top infectious disease killer a possibility with Otago discovery

Researchers at University of Otago have discovered a novel property of Bedaquiline, a new anti-tuberculosis drug that could help develop more effective treatments for tuberculosis. The study's findings suggest that the drug works by disrupting energy generation in Mycobacterium tuberculosis cells, offering potential for designing more ...

SourceUniversity of Otago·JournalProceedings of the National Academy of Sciences·DateJul 2, 2018

New drug and material discoveries to be untangled in VR

Scientists at the University of Bristol have developed new virtual reality cloud-based tools to accelerate research tasks in drug and material discovery. Using real-time molecular simulations, researchers can now interact with molecules in a virtual space, folding, knotting, and changing their shape to test interactions.

SourceUniversity of Bristol·JournalScience Advances·DateJul 2, 2018

What the satellites in your body do

Researchers found that hSATa satellite RNA directly interferes with DNA copying and damage repair in cells, leading to breast cancer. This discovery suggests targeting satellite RNAs could provide another approach for treating various cancers, including breast, ovarian, prostate, and pancreatic cancer.

SourceSalk Institute·JournalMolecular Cell·DateJul 2, 2018

The spliceosome: The tailor that coordinates the 'snip and stitch' of genetic information

The study reveals the Spp42 protein plays a crucial role in regulating spliceosome components, essential for transforming genetic information into functional proteins. This understanding may lead to new drugs targeting the spliceosome function to treat diseases such as cancer and leukemia.

SourceScuola Internazionale Superiore di Studi Avanzati·JournalProceedings of the National Academy of Sciences·DateJul 2, 2018

Discovery of new biomarker could provide personalized treatment options for bladder cancer

Researchers at Mount Sinai have discovered two microRNA activity-based biomarkers that can predict patient outcomes and inform treatment decisions for p53-like bladder cancer. The findings hold promise for personalized treatment options, but further research is needed to translate the results into improved patient care.

Can aspirin treat Alzheimer's?

A study published in The Journal of Neuroscience found that low-dose aspirin may reduce plaques in the brain by stimulating lysosomes and increasing the activity of TFEB, a protein responsible for waste removal. This could lead to improved treatment options for Alzheimer's disease.

A new twist on how parasites invade host cells

Toxoplasmosis is a widespread infection caused by the parasite Toxoplasma gondii, which multiplies within a host and causes irreversible tissue damage. The parasite implements an ingenious invasive strategy involving a protein complex and rotational force to gain entry to host cells.

SourceCNRS·JournalCell Host & Microbe·DateJul 2, 2018

Athletic 'pull' increases campus diversity

Research by Penn State's Clio Andris found that universities attract athletes from afar, increasing diversity on campuses. The study analyzed data from over 160,000 student-athletes and found that Ivy League schools and less centrally located schools have strong pull rankings.

SourcePenn State·JournalThe Professional Geographer·DateJul 2, 2018

Patients don't mind if doctors sport tattoos or piercings

A study of nearly 1000 emergency care patients found that visible body art has no discernible impact on perceived professionalism or competence. Patients rated doctors with tattoos and piercings highly for qualities such as caring attitude, approachability, and trustworthiness.

SourceBMJ Group·JournalEmergency Medicine Journal·DateJul 2, 2018

Eat 'em up: Next-generation therapeutic helps immune cells detect, destroy cancer

Researchers at Brigham and Women's Hospital have developed a supramolecular therapeutic that blocks the 'eat me not' signal sent by cancer cells and converts macrophages to the attacking M1 subtype. The approach has yielded promising results in preclinical models, showing complete inhibition of tumor growth and increased survival rates.

SourceBrigham and Women's Hospital·JournalNature Biomedical Engineering·DateJul 2, 2018

Is the Bitcoin network an oligarchy?

Researchers found a circle-type structure within Bitcoin transactions, revealing hidden communities of interconnected owners. A small fraction of users holds the majority of the network's wealth.

SourceSpringer·JournalThe European Physical Journal B·DateJul 2, 2018